{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:45:19Z","timestamp":1777934719485,"version":"3.51.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"17_Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"DOI":"10.2146\/ajhp150519","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T10:07:39Z","timestamp":1471601259000},"page":"S126-S132","source":"Crossref","is-referenced-by-count":17,"title":["Impact of a pharmacist-driven protocol to decrease proton pump inhibitor use in non-intensive care hospitalized adults"],"prefix":"10.1093","volume":"73","author":[{"given":"Jessica","family":"Michal","sequence":"first","affiliation":[{"name":"CaroMont Health, Gastonia, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Henry","sequence":"additional","affiliation":[{"name":"CaroMont Health, Gastonia, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Street","sequence":"additional","affiliation":[{"name":"CaroMont Health, Gastonia, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041102205408600_b1-073s126","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/j.ijid.2011.03.017","article-title":"Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection","volume":"15","author":"Musgrave","year":"2011","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t2019041102205408600_b2-073s126","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajg.2012.179","article-title":"Clostridium difficile\u2013associated diarrhea and proton pump inhibitor therapy: a meta-analysis","volume":"107","author":"Janarthanan","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019041102205408600_b3-073s126","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.mayocp.2013.07.004","article-title":"Proton pump inhibitors and the risk for hospital-acquired Clostridium difficile infection","volume":"88","author":"Barletta","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019041102205408600_b4-073s126","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile\u2013associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"issue":"suppl 2","key":"key\n\t\t\t\t2019041102205408600_b5-073s126","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1017\/S0899823X00193857","article-title":"Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update","volume":"35","author":"Dubberke","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"suppl 2","key":"key\n\t\t\t\t2019041102205408600_b6-073s126","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/cid\/cis335","article-title":"Burden of Clostridium difficile on the healthcare system","volume":"55","author":"Dubberke","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041102205408600_b7-073s126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.18553\/jmcp.2010.16.2.114","article-title":"Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward","volume":"16","author":"Khalili","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"key\n\t\t\t\t2019041102205408600_b8-073s126","doi-asserted-by":"crossref","first-page":"696.e11","DOI":"10.1016\/j.jcrc.2014.03.002","article-title":"Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile\u2013associated diarrhea","volume":"29","author":"Buendgens","year":"2014","journal-title":"J Crit Care"},{"key":"key\n\t\t\t\t2019041102205408600_b9-073s126","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ajg.2012.108","article-title":"Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","volume":"107","author":"Kwok","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019041102205408600_b10-073s126","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/ajhp\/56.4.347","article-title":"ASHP therapeutic guidelines on stress ulcer prophylaxis","volume":"56","author":"American Society of Health-System Pharmacists","year":"1999","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041102205408600_b11-073s126","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2146\/ajhp060393","article-title":"Stress ulcer prophylaxis in hospitalized patients not in intensive care units","volume":"64","author":"Grube","year":"2007","journal-title":"Am J Health-Syst Pharm"},{"key":"key\n\t\t\t\t2019041102205408600_b12-073s126","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1503\/cmaj.1040876","article-title":"Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies","volume":"171","author":"Dial","year":"2004","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t2019041102205408600_b13-073s126","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/CCM.0b013e3181d69ccf","article-title":"The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis","volume":"38","author":"Lin","year":"2010","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t2019041102205408600_b14-073s126","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ajg.2011.474","article-title":"Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis","volume":"107","author":"Barkun","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019041102205408600_b15-073s126","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/CCM.0b013e3182758734","article-title":"Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t2019041102205408600_b16-073s126","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/1060028014540513","article-title":"Histamine-2-receptor antagonist administration and gastrointestinal bleeding when used for stress ulcer prophylaxis in patients with severe sepsis or septic shock","volume":"48","author":"Barletta","year":"2014","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041102205408600_b17-073s126","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1097\/CCM.0b013e3181f17adf","article-title":"Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis","volume":"38","author":"Marik","year":"2010","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t2019041102205408600_b18-073s126","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archinternmed.2011.14","article-title":"Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding","volume":"171","author":"Herzig","year":"2011","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041102205408600_b19-073s126","doi-asserted-by":"crossref","first-page":"562","DOI":"10.7326\/0003-4819-106-4-562","article-title":"Prophylactic therapy for stress ulcer bleeding: a reappraisal","volume":"106","author":"Shuman","year":"1987","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041102205408600_b20-073s126","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejim.2010.06.010","article-title":"Stress-related mucosal disease: incidence of bleeding and the role of omeprazole in its prophylaxis","volume":"21","author":"Amaral","year":"2010","journal-title":"Eur J Intern Med"},{"key":"key\n\t\t\t\t2019041102205408600_b21-073s126","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1572-0241.2006.00839.x","article-title":"Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients","volume":"101","author":"Heidelbaugh","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019041102205408600_b22-073s126","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.02.014","article-title":"Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients","author":"Buckley","year":"2015","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041102205408600_b23-073s126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4140\/TCP.n.2011.485","article-title":"The impact of pharmacist interventions on the inappropriate use of acid-suppression therapy","volume":"26","author":"Hughes","year":"2011","journal-title":"Consult Pharm"},{"key":"key\n\t\t\t\t2019041102205408600_b24-073s126","doi-asserted-by":"crossref","first-page":"344","DOI":"10.18553\/jmcp.2009.15.4.344","article-title":"Results of an intervention in an academic internal medicine clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a Tennessee Medicaid formulary change","volume":"15","author":"Ramser","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"key\n\t\t\t\t2019041102205408600_b25-073s126","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/73\/17_Supplement_4\/S126\/28334027\/ajhps126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T18:51:14Z","timestamp":1657133474000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/73\/17_Supplement_4\/S126\/5101820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":25,"journal-issue":{"issue":"17_Supplement_4","published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150519","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9,1]]},"published":{"date-parts":[[2016,9,1]]}}}